Key facts
- This page summarizes Glenn Coleman's Form 4 filing for DENTSPLY SIRONA Inc. (XRAY).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 15 Oct 2024, 16:30.
Glenn Coleman - 11 Oct 2024 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)
- Reporting relationship
- Executive VP & CFO
- Issuer ticker
- XRAY
- Reported as of
- 11 Oct 2024
- Net transaction value
- +$301
- SEC form
- 4
- Accepted by SEC
- 15 Oct 2024, 16:30:13 UTC
- Prior SEC filing
- 15 Jul 2024
- Next SEC filing
- 12 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dane Baumgardner, Attorney-In-Fact for Glenn Coleman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Glenn Coleman filed Form 4 for DENTSPLY SIRONA Inc. (XRAY) on 15 Oct 2024.
Change
- Previous filing in this sequence was filed on 15 Jul 2024.
- Current net transaction value: +$301.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
XRAY
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +375
- Change %
- +0.42%
- Price
- $0.000000
- Shares after
- 89,768
- Date
- 11 Oct 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
XRAY
transaction
Derivative
Phantom Stock (Supplemental Executive Retirement Plan) SERP
Award
- Transaction value
- $301
- Shares
- +12
- Change %
- +0.65%
- Price
- $24.50
- Shares after
- 1,892
- Date
- 11 Oct 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
Footnote F2
Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.
Footnote F3
Comprised of phantom stock acquired as a result of accrued dividends.